—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Revvity Inc. (RVTY) — chart, structure and Closelooknet read

The Closelooknet read

Revvity supplies instruments, reagents, software and diagnostic platforms used to screen for genetic disorders, infectious disease and early childhood conditions, and separately provides genomic workflow tools for drug discovery. It serves pharmaceutical companies, laboratories, academic institutions, public health authorities and hospitals.

Detail below: the desk's view, the earnings record, peers and the company snapshot; daily prices on the price-history tab. Research diary readings, not advice.

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for RVTY, from the same nightly bakes the boards use. Research diary readings, not advice.

Mentioned on Closelooknet 1 piece · newest: Midday 10, “A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000” (2026-08-21)

Mentioned on Closelooknet

Where RVTY appears in the diary — 1 piece, newest first. Every link is our own writing.

Dailies

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 47/100 · S&P 500 fund at 48, above its 200-day averageEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-11-06
  • Factor regime Defensive rotation — low-vol leading, regime-change watchMomentum against low volatility (SPMO / SPLV): below its 50-day trend, 60th percentile of the window, -22.8% over 20 sessions. Factor regime → 2026-11-06
  • Sovereign pressure Index -1.91 · down 2.45 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-11-06
How it trades on rate days beta 0.68 to TLT · on the worst bond days it held up better than the market

How it trades on rate days

How RVTY has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 0.68 — moves strongly with bonds for every 1% move in TLT (20+ year Treasuries), Revvity Inc. moved 0.68% on average · correlation 0.16 · higher than 61% of US names
  • Beta, last 3 months −0.30 less rate-sensitive lately than over the year
  • On the 10 worst bond days −0.09% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days +6.03% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Diagnostics & Research · United States · 8 names with week and year-to-date

Peer group

Diagnostics & Research · United States

This name carries no Closelooknet score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against RVTY on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Revvity Inc.

RVTY in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Revvity supplies instruments, reagents, software and diagnostic platforms used to screen for genetic disorders, infectious disease and early childhood conditions, and separately provides genomic workflow tools for drug discovery. It serves pharmaceutical companies, laboratories, academic institutions, public health authorities and hospitals. The company is based in Waltham, Massachusetts.
Where it sits in the stack
Revvity holds no seat in Rubin, our AI infrastructure index; it sits instead in the Diagnostics & Research sleeve of the wider Healthcare sector we track. Its business runs on laboratory testing and genomic screening demand rather than on the compute build-out, so it is not a constraint on or a customer of the AI stack itself.
Who it is priced against
The diary's records carry no defined peer group for Revvity. The name the market most often sets alongside it is Thermo Fisher Scientific, another supplier of instruments and reagents to laboratories and health-care researchers.
Why Closelooknet tracks it
Revvity is a constituent of the S&P 500 and does not carry a Closelooknet score, so no module has yet been built for it. The diary has quoted it once, in a Midday 10 edition, as one of several health-care and biotech names reaching new highs alongside broader market moves that day.
What the diary watches
The diary watches whether demand for early-detection diagnostics and genomic sequencing tools continues to support Revvity's testing and screening business, and whether future coverage brings it a defined peer group or a scored module.

Revvity Inc. (RVTY) trades on US exchanges.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

The Street on this name 2 analyst actions on the wire · latest: initiation by William Blair, 2026-10-05

The Street on this name

Analyst actions and the latest print for RVTY from the Closelooknet wires — third-party opinions on the record, not our readings.

  • Initiation William Blair — at Outperform Initiated to Outperform 2026-10-05
  • Price target KeyBanc — target 165 from 125 Target raised to $165 from $125 (+26.3% to spot) 2026-09-04

2 actions on the analyst wire since 2026-08-13: 1 initiation, 1 target change. Analyst wire → · Earnings wire →

Dividends and capital return trailing yield 0.05%, annual · last 0.0700 USD on 2026-04-17

Dividends and capital return

What RVTY pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 0.0700 USD per share · a 0.05% yield on the 2026-11-06 close 1 distribution, paid once a year 2026-11-06
  • Change on the year −66.7% against the prior twelve months prior twelve months 0.21 USD per share
  • Last distribution 0.0700 USD per share as the price series records it, within days of the ex-date 2026-04-17
  • By calendar year 2025: 0.21 USD (partial) · 2026: 0.0700 USD to date first distribution recorded in the three-year window: 2025-04-17

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-11-07

Quick answers

What is Revvity Inc. (RVTY)?

Revvity Inc. trades as RVTY on the US exchange (United States) in the Closelooknet research universe, as of the registry build of 2026-11-07.

Is RVTY in a Closelooknet index?

Not currently — Revvity Inc. is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-11-07.

Where does RVTY trade against its moving averages?

Revvity Inc. trades 5.2% above its 50-day and 37.4% above its 200-day moving average (1.2% below its 20-day). As of 2026-11-06 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Revvity Inc. compare with its peers?

Against its peer group (Diagnostics & Research · United States), Revvity Inc. (RVTY) sits 9.7% below its 52-week high, 5.2% above its 50-day average; Mettler-Toledo International Inc (MTD) is 4.7% below, Labcorp Holdings Inc. (LH) is 1.8% below, Charles River Laboratories (CRL) is 11.1% below, as of 2026-11-06. Put any of them next to RVTY in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.

How does Revvity Inc. trade when bond yields rise?

Over the past year Revvity Inc. had a beta of 0.68 to TLT, the long-dated Treasury fund — it moves strongly with bonds, higher than 61% of US names. On the 10 sessions in which long bonds fell most it moved −0.09% on average, against −0.74% for the S&P 500. As of 2026-11-06; The "How it trades on rate days" block on this page carries the lines.

Where has Closelooknet written about Revvity Inc.?

Revvity Inc. appears in 1 Closelooknet piece as of 2026-11-07, most recently Midday 10: A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000 (2026-08-21). What Closelooknet said most recently: Barchart's large-cap 52-week new-high list, as of 11:59 CDT, carries 31 names and reads like the ex-tech thesis printed as breadth: twelve are health care, biotech or pharma — ARGX, BDX, BIO, CORT, HALO, MRK, REGN, RVTY, THC, TVTX, TXG… (Midday 10, 2026-08-21). The "Mentioned on Closelooknet" block on this page lists the long reads, the reference entries and the dailies that name it.

What does Revvity Inc. do?

Revvity supplies instruments, reagents, software and diagnostic platforms used to screen for genetic disorders, infectious disease and early childhood conditions, and separately provides genomic workflow tools for drug discovery. It serves pharmaceutical companies, laboratories, academic institutions, public health authorities and hospitals. The company is based in Waltham, Massachusetts. The diary's records carry no defined peer group for Revvity. The name the market most often sets alongside it is Thermo Fisher Scientific, another supplier of instruments and reagents to laboratories and health-care researchers. (Company snapshot of 2026-09-17.)

Where does Revvity Inc. sit in the AI build-out?

Revvity holds no seat in Rubin, our AI infrastructure index; it sits instead in the Diagnostics & Research sleeve of the wider Healthcare sector we track. Its business runs on laboratory testing and genomic screening demand rather than on the compute build-out, so it is not a constraint on or a customer of the AI stack itself. Revvity is a constituent of the S&P 500 and does not carry a Closelooknet score, so no module has yet been built for it. The diary has quoted it once, in a Midday 10 edition, as one of several health-care and biotech names reaching new highs alongside broader market moves that day. (Company snapshot of 2026-09-17.)

Does Revvity Inc. pay a dividend?

Revvity Inc. has paid 0.0700 USD per share over the last twelve months, paid once a year, a trailing yield of 0.05% on the 2026-11-06 close; the last distribution recorded in the price series was 0.0700 USD on 2026-04-17. As of 2026-11-06; the "Dividends and capital return" block on this page carries the lines.

What has Wall Street done on Revvity Inc. recently?

The most recent analyst action on Revvity Inc. on the Closelooknet wire is a initiation by William Blair on 2026-10-05 (at Outperform). 2 actions on the analyst wire since 2026-08-13: 1 initiation, 1 target change. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for RVTY, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

How to use this chart

Toolbar

  • Range — 1M to MAX on daily closes. 1D/5D switch a US stock cell to 5-minute intraday bars; index and foreign cells fall back to 1M daily with a note.
  • Grid — 1×1 up to 2×2. Cells are synchronized: pan or zoom one and the others follow the same dates; the crosshair tracks across all of them. 4 INDICES loads Rubin · HALO · AEI · AW40 side by side.
  • Type / Scale — OHLC, line or area; linear or log price axis.

Picking a series

  • Tap the box in a cell's header to browse every Closelooknet series — headline indices, sub-indices, sectors, layers of all six families — plus the constituents.
  • Or type any ticker (NVDA, 7203.T, ASML.AS …) and press Enter — it charts in the cell straight from our data lake.

Studies

  • Overlays / Oscillators rows toggle the standard set (SMA, Bollinger, RSI, MACD …) per cell.
  • Levels (stock cells) draws the structure engine's support lines — regression bands, pivot cluster, SMA-200, the active fib zone.

Drawing

  • Tap a tool (Trend, Ray, H-Line, Fib, Channel, Rect, Note), then tap the chart once per point — the shape follows your finger or cursor between taps. The chart stops panning while a tool is armed; tap the tool again to release.
  • Drawings save per symbol in this browser and travel between the terminal and the asset page.
  • Delete key removes the selected drawing · Escape cancels a half-placed one · Clear wipes the symbol.

Wave counts

  • Wave places an Elliott count: tap the origin, then each wave end. Press Enter to stop early (inside wave 3 is fine) — dotted ghost targets sketch the remaining waves at guideline ratios.
  • On stocks the scanner's machine count appears automatically in grey — it is fully editable: drag any point, double-tap a label to remove it, Delete to dismiss it for good, Adopt to bring the machine's proposal back.
  • The sequence picker switches 1-5 / A-B-C / A-E / W-X-Y-Z; 1 2 3 cycles the degree; Subdiv starts a one-degree-smaller child count inside a wave.

Sharing

  • Card exports the cell as a branded PNG — chart, drawings and levels exactly as shown.

Related in the Closelooknet universe

then Diagnostics & Research. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.